[HTML][HTML] Effectiveness and safety of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: Results of A real-world study in a metropolitan area of …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - mdpi.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of …
E Crocetti, S Cattaneo… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
[PDF][PDF] Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of a Real-World Study in a Metropolitan Area …
E Crocetti, S Cattaneo, W Bergamaschi, S De Servi… - J. Clin. Med, 2021 - researchgate.net
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of …
E Crocetti, S Cattaneo… - Journal of Clinical …, 2021 - search.ebscohost.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
[HTML][HTML] Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - search.proquest.com
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of …
E Crocetti, S Cattaneo, W Bergamaschi… - Journal of Clinical …, 2021 - europepmc.org
Background: New oral anticoagulant agents (NOACs) are valid alternatives for vitamin K
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …
antagonists (VKA) in patients with non-valvular atrial fibrillation (NVAF) for stroke prevention …